[Opioid-related disorders].
Funada
Masahiko
M
National Institute of Mental Health, National Center of Neurology and Psychiatry.
D001521:Behavior Therapy / Q000379:methods; D002047:Buprenorphine / Q000627:therapeutic use; D039721:Diagnostic and Statistical Manual of Mental Disorders; D006801:Humans; D038801:International Classification of Diseases; D008691:Methadone / Q000627:therapeutic use; D009270:Naloxone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D009294:Narcotics / Q000627:therapeutic use; D009293:Opioid-Related Disorders / Q000175:diagnosis / Q000209:etiology / Q000628:therapy
D009292:Narcotic Antagonists; D009294:Narcotics; D009270:Naloxone; D002047:Buprenorphine; D008691:Methadone